The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I still smell more news to follow. USA will most certainly like this alone anyway!
If I were a betting man I'd expect to see more than one today after this.
Hi papanna. You may benefit from AA meetings. Message Nelsonthedog for the details. Plenty of sponsors around.
Did somebody mention AccuStem? I've heard it's a myth...
Enjoyed that Chisler. HMS Trumpet?
Something something obligatory out over the weekend post. Couldn't resist.
Love it when you appear. Last time you were active the MCAP rose 100%. You're like lucky pants. Bit grubby but a good sign when they're back on the floor.
"The topline data from the trial is expected to be available in January 2021."
Expected - that's not too solid a deadline so if they go over not unexpected.
Available - probably to them not us. We will get our update in due course
Sorry have to call you out on this. Not sure if you're trying to destabilise or just haven't looked into it correctly? Brian has turned the agenda around for GWMO by shifting what their main target is. The tailings, mine extensions and previously unexplored acreage is his push and it's a great move.
If I see another "boo hoo where are my AccuStem I'm entitled to" post before the end of Q1 I'm going to have to open the green bin.
Results in and sorted tomorrow. RNS monday
Really? I had movement in this range as expected personally given the clearing of placings and warrants. Actually been impressed with the resilience of the price myself. Just an opinion of course.
Agree Oldapache.
Here's my view simplified.
TILS: "Hi Nadaq looks like we might need up to $250m soon as we have loads to do!"
Nasdaq: "Sure thing TILS. Your current price is £1.50. You're going to have to put in a minimum of 62million shares in the kitty if you want that much at today's price. Can't say yes unless you deposit that many shares just in case."
TILS: "Sure no problem. We expect to get way more per ADR than that anyway so we'll raise the 250m without needing all 62m shares."
Nasdaq: "I like your confidence but still need you to sign to say 62m will be available if I'm going to let have the ability to make that extra $250m for whatever you're doing"
TILS: "Understood those are the rules!"
This may seem childish but it is clearer.
A pleasure to have you back Rise. You'll be pleased to know that the board already have roughly 25% yes by my own contacts. Good to see you're as radiant as ever.
I believe there may be crossed wires here Axe-Capital, as I too was up at 2am reading and on the phone discussing the form. I may have poorly described my position so I shall try again. Yes the ordinary shares were registered ($250m at the time on 25/01/2021) but it does clearly state the following on the form;
"We may, from time to time, offer to sell the securities through public or private transactions, directly or through underwriters, agents or dealers, on or off The Nasdaq Global Market, ***at prevailing market prices or at privately negotiated prices.***
This sounds to me like it is indeed NOT a flat 150p per share but that a maximum of $250m or transactions can take place. Please again correct me if this is misinterpreted.
Axe-Capital I believe you may be stating opinion as fact. Where are the number of shares on the form f-3? They aren't there. As it is based on value at opportune time, not a fixed value. Feel free to correct me on this but I'm pretty certain.
Maybe they need more in circulation for a merger
I personally don't doubt this share at all. The science is sound from what I've seen and as clinical trials enter phase 3 across the board we will be in a very different situation. Until then I suggest switching off. It's all very exciting right now but the real excitement is when one of our many treatments is finalising phase 3 for a chronic condition.
Agree with all of the rest though.
That is outdated. Q1 2021 is the expected listing. Don't know why everyone is so keen to sell out of AccuStem.
Brexit means you have to change what "channel" shares are dealt with. It's about as exciting as switching your electoral role after you move house